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Abstract
Background: Genome-wide screening in human and mouse cells using RNA interference and open reading frame
over-expression libraries is rapidly becoming a viable experimental approach for many research labs. There are a
variety of gene expression modulation libraries commercially available, however, detailed and validated protocols
as well as the reagents necessary for deconvolving genome-scale gene screens using these libraries are lacking. As
a solution, we designed a comprehensive platform for highly multiplexed functional genetic screens in human,
mouse and yeast cells using popular, commercially available gene modulation libraries. The Gene Modulation Array
Platform (GMAP) is a single microarray-based detection solution for deconvolution of loss and gain-of-function
pooled screens.
Results: Experiments with specially constructed lentiviral-based plasmid pools containing ~78,000 shRNAs
demonstrated that the GMAP is capable of deconvolving genome-wide shRNA “dropout” screens. Further
experiments with a larger, ~90,000 shRNA pool demonstrate that equivalent results are obtained from plasmid
pools and from genomic DNA derived from lentivirus infected cells. Parallel testing of large shRNA pools using
GMAP and next-generation sequencing methods revealed that the two methods provide valid and complementary
approaches to deconvolution of genome-wide shRNA screens. Additional experiments demonstrated that GMAP is
equivalent to similar microarray-based products when used for deconvolution of open reading frame over-
expression screens.
Conclusion: Herein, we demonstrate four major applications for the GMAP resource, including deconvolution of
pooled RNAi screens in cells with at least 90,000 distinct shRNAs. We also provide detailed methodologies for
pooled shRNA screen readout using GMAP and compare next-generation sequencing to GMAP (i.e. microarray)
based deconvolution methods.
Background
Beginning in the late 1990’s, construction of a systema-
tic, barcoded gene deletion strain collection in S. cerevi-
siae set the stage for high throughput functional
screening in eukaryotes [1,2]. Researchers using that
resource developed powerful functional genomics
screening approaches, and significantly, introduced the
concept of performing complex, pooled population
screens to simultaneously interrogate an organism’s
entire genome to identify drug targets, synthetic genetic
interactions and other phenomena [1,3-7]. Similarly, the
contemporary development of large libraries of short
hairpin RNAs (shRNAs) and open reading frame (ORF)
collections has significantly expanded the research
toolkit available for performing mammalian functional
genetics in a comprehensive manner [8-11]. The devel-
opment of such tools, combined with the years of les-
sons from yeast-based screens suggested that similar
genome-wide screens using a ‘barcoded pool’ screening
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[12,13]. Indeed, several groups have demonstrated the
impressive ability of pooled RNAi dropout screens to
identify genes essential to cancer cell proliferation
[14-18]. Based on these early reports, pooled RNAi
screens hold great promise for identifying genes impor-
tant for growth, metabolism, differentiation, DNA
damage response, sensitivity/resistance to therapeutics
and many other processes in both normal and diseased
cells.
Linking phenotypic changes to gene dosage in a het-
erogeneous population of cells requires a stably inher-
ited molecular tag, such as a DNA barcode, that
uniquely associates the phenotype with the perturbagen.
A decade of work with yeast and other microbes has
shown that DNA barcodes are sensitive and quantitative
genetic markers that permit cell-based screening in high
complexity pooled formats, with subsequent deconvolu-
tion by amplification of barcodes followed by microarray
hybridization or high throughput DNA sequencing
[19-21]. In contrast to the yeast knock-out strains, for
pooled shRNAs and ORFs the growth perturbing agents
themselves can serve as specific barcodes because they
consist of uniquely identifiable DNA sequences. This
approach has been demonstrated in several recent publi-
cations using different shRNA libraries [14-17]. For each
publication, a different custom array was built and qual-
ity controlled, but information on the optimization and
validation was limited, and the microarrays were not
made commercially available. Consequently, researchers
interested in utilizing this technology would need to
perform resource intensive optimization and quality
assurance on a new custom microarray for each shRNA
library - an approach that is cost-inefficient, and does
not promote standardized datasets amenable to high
level informatics analysis. In order to facilitate loss-of-
function and gain-of-function pooled screens using
commercially available gene modulation libraries, we
designed and validated a single microarray detection
platform for deconvolution of loss- and gain-of-function
pooled screens in human, mouse and yeast cells.
One can now easily procure custom microarrays
designed to detect novel barcoded libraries. In order to
evaluate and maximize the effectiveness of such bar-
coded platforms, extensive testing and optimization is
required. For gene expression studies, extensive develop-
ment work has already been done for a number of
detection platforms and, as a result, they have become
straightforward and routine to use. For new custom bar-
coded systems, similarly rigorous testing, optimization
of protocols, and development of quality control stan-
dards must be done. This manuscript describes a
detailed evaluation and analysis of the performance of
t h eG e n eM o d u l a t i o nA r r a yP l a t f o r m( G M A P )
microarray, and carefully optimized protocols for every
step of the process from sample preparation to data
analysis. In essence, we provide a guide to use the
GMAP chip as well as highlight the design principles
and quality control measures that may be useful for
other customized microarray platforms. In addition, we
have also developed a software tool (using open source
scripts) for use in extracting and analysing the data
from the GMAP.
Results and Discussion
We designed the multipurpose, cost-effective GMAP to
enable researchers to inexpensively and comprehensively
collect data from genome-scale pooled gene-dosage
modulation screens performed in human, mouse, and
yeast cells using commercially available gene modulation
libraries on a standard platform. Specifically, the GMAP
enables readout of clone enrichments and depletions
from pooled screens using the RNAi consortium (TRC)
human and mouse libraries [11,14,22], human ORF
expression pools [23,24], and pooled screens using gene
deletion-associated barcodes or ORFs from budding
yeast[1,25].
The detection features on GMAP are summarized in
Table 1. The GMAP features encompass the entire
TRC1 shRNA human and mouse collections and a por-
tion of the greatly expanded TRC2 collection such that
>248,000 unique shRNAs from the TRC collection can
potentially be assayed in parallel. To achieve this extra-
ordinary density, GMAP features were synthesized at a
5 μm scale, resulting in a 4.84-fold smaller surface area
than the 11 μm features on the TRCBC array, a com-
mercially unavailable microarray that was previously
generated to perform pooled shRNA screens on a subset
of the TRC1 shRNA collection [14]. We based the
design of the GMAP shRNA features on observations
from the TRCBC microarray which included three dif-
ferent, but highly overlapping sequences to detect each
s h R N A [ 1 4 ] .O n eo ft h e s et h r e ef e a t u r ed e s i g n sw a s
superior to the others in tests using engineered pools
with known relative shRNA compositions (Additional
file 1, Figure S1). The GMAP chip starts with the best
performing feature design and adds one base from the
21-base shRNA stem sequence to extend the feature
length from 21 to 22 bases. Three identical replicates
per shRNA barcode feature were included on the
GMAP microarray. This strategy was used to maximize
signal-to-noise and to identify and potentially correct
for any subtle shRNA processing inconsistencies without
significantly impacting specificity.
In order to achieve consistent results, a simple-to-fol-
low standard operating procedure (SOP) was developed
for preparing samples for hybridization (see Additional
file 2 for detailed protocols and recipes). As part of the
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Page 2 of 13SOP optimization process, a standardized amount of
shRNA probe was hybridized to the GMAP array. Hybri-
dizations were performed with quantities of 1 μg, 2 μg,
and 3 μg of purified shRNA probe (see Materials and
Methods)t h a tw a sg e n e r a t e df r o map l a s m i dp o o lo f
78,432 (78 k) human shRNAs (Additional file 1, Figure
S2a). 2 μg of probe gave the best signal-to-noise ratio and
was therefore chosen as the standard quantity for all 78 k
pool hybridizations. For pools of different complexity, the
amount of probe applied to GMAP is altered proportion-
ally compared to the 2 μgu s e df o r7 8kp o o l s( f o re x a m -
ple ~1.35 μg for 54 k pools). In addition to optimizing
the quantity of probe, a range of hybridization and wash-
ing temperatures were tested using 2 μgo f7 8ks h R N A
pool probe. Hybridization was tested at 40°C and 45°C,
with washing tested at 30°C and 35°C. Hybridization at
40°C, with array washing at 30°C was found to provide
the highest probe signal with minimal signal from fea-
tures corresponding to shRNAs not included in the pool
(Additional file 1, Figure S2b).
To assess GMAP chip performance with complex
shRNA populations, probe generated from the 78 k
human shRNA pool or a different 78 k mouse shRNA
pool was hybridized and analyzed. Signal intensity histo-
grams and cumulative distribution plots generated from
the collected data indicate that the signal intensities for
probes corresponding to shRNAs present in the 78 k
pools were well resolved from the background signal of
GMAP features corresponding to shRNAs not present
in the pools (Additional file 1, Figure S3a,b). The small
overlap between the signals for features matched to
either of the human or mouse shRNA pools versus the
features that have no matching shRNA in the corre-
sponding pools indicates low rates of library composi-
tion errors and cross-hybridization. A surface plot of
intensities for all shRNA features on the GMAP array
for the human 78 k pool versus the mouse 78 k pool
indicates that large pools of equal complexity can be
easily resolved from each other (Spearman correlation R
< 0.01) and from shRNA features not corresponding to
either experimental pool (Figure 1a).
One major application of pooled shRNA screens is to
perform negative selection screens, so called “dropout
screens”, in cancer cell lines to identify cancer-essential
genes that represent potential therapeutic targets. To
assess the performance of the GMAP in deconvolving
genome-scale shRNA drop-out screens, we first calcu-
lated a minimum signal in the reference data for inclu-
sion in analysis. This was accomplished by adding 1.96
standard deviations (the 95% confidence limit) to the
mean background log signal measured on human 78 k
pool hybridizations, yielding a threshold of log2 =7 . 8 9
(Additional file 1, Figure S3c). Consequently, 89.9% of
the shRNA signals in the reference data exceeded this
threshold and were retained for analysis. We simulated
shRNA dropout screens by altering the concentration of
sub-fractions of the human 78 k pool in two different
shRNA dilution experiments. The first approach utilized
four different 78 k human pools, each containing the
same 78,432 shRNAs. Approximately 70,100 shRNAs
were present in equal concentration in all four pools,
while an identical sub-fraction of ~8,300 shRNAs were
either undiluted (the reference “Even pool”), or diluted
4-fold, 16-fold, or 64-fold (the “4x”, “16x” and “64x”
pools” respectively). Distribution plots of shRNA log2
signal intensity difference between the diluted pools and
the Even pool demonstrate that the diluted subpools
can be distinctly resolved from each other (Figure 1b).
In a second approach, we constructed a single 78 k
shRNA pool (the “2x-20x” pool) in which, relative to the
bulk population, four distinct subsets of ~8400 shRNAs
each were diluted 2-fold, 5-fold, 10-fold and 20-fold,
respectively. Similar to the previous experiment, distri-
bution plots of shRNA signal difference between diluted
pools and the reference population in the Even pool
demonstrate that the diluted subpools are resolvable
(Figure 1c). We did observe that the signal reduction in
diluted subpools on the GMAP chip is not directly pro-
portional to the dilution factor, indicating that changes
in microarray signal are not linearly proportional to
shRNA concentration across the full observed signal
range. In particular, the subpool dilution signals are
Table 1 Description of the features on the UT GMAP 1.0
Probe ID Description Unique probes Replicates Total number of probes Probe length
hORF Human ORFeome 134901 1 134901 25
huORF HuGene ORFs 58087 1 58087 25
HP shRNA sequences (mouse and human) 248049 3 744147 22
HPC shRNA negative controls 138 33 4554 22
HSPI Hybridization spike-in probes 200 25 5000 22
HPTMM shRNA mismatch control probes 8097 3 24291 22
TAG Yeast barcode probes 26801 3 80403 20
yORF Yeast open reading frames 11421 1 11421 25
Total NA 487694 NA 1062804 NA
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Page 3 of 13spaced more closely, or compressed, than would be
expected for a linear concentration versus signal
relationship.
To assess the performance of GMAP relative to the
lower density and previous generation TRCBC array, we
amplified shRNA probes from genomic DNA extracted
from human BT-474 cells infected with a ~54,000
shRNA pool of lentiviruses corresponding to all avail-
able human shRNA features on the TRCBC chip,
divided the probe and hybridized samples to both
TRCBC and GMAP chips. Comparison of signal inten-
sity between the two different array formats revealed a
Spearman correlation coefficient of R = 0.96 (Additional
file 1, Figure S4). This result confirms that moving from
11 μm feature sizes to 5 μm feature sizes does not cause
any significant reduction in signal strength or specificity,
agreeing with reported observations on yeast barcode
arrays [26].
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Figure 1 Readout of high complexity shRNA pools. (a) Surface plot of signal intensities for all 248,049 shRNA features on the GMAP
microarray following hybridization of probe generated from the human 78 k plasmid shRNA pool or the mouse 78 k plasmid shRNA pool. The
surface plot shows the signal intensity distributions of the human and mouse 78 k features plotted against each other and the remaining shRNA
probe features not corresponding to either pool. The signal peaks are labelled according to which set of features they represent. (b) Distribution
plots of GMAP features data for a dilution series of shRNAs in separate pools. 4x, 16x, and 64x curves are plotted as the distribution of log2
difference between the array signal for shRNAs in the dilution series and their signal in the reference (Even) pool. The 1x curve is plotted as the
log2 difference between a group of undiluted shRNAs in the 4x pool and the same shRNAs in the Even pool. (c) Distribution plots of GMAP
array data for a dilution series of shRNAs within the same pool. 2x, 5x, 10x, and 20x curves are plotted as the distribution of log2 difference
between the array signal for groups of diluted shRNAs and their signal in the reference (Even) pool. The 1x curve is plotted as the log2
difference between a group of undiluted shRNAs in the 2x-20x pool and the same shRNAs in the Even pool. All microarrays were run in
triplicate, and the replicate signal intensities were averaged.
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Page 4 of 13To compare the BAR-seq strategy [20] with microar-
ray detection for shRNA barcodes, we used Illumina
next-generation sequencing technology to enumerate
barcodes in the same five human shRNA 78 k pools
described above (Even, 4x, 16x, 64x and 2x-20x).
Sequencing libraries were prepared from these pools via
essentially the same approach used for generating
labelled shRNA barcodes for the GMAP array, followed
by an additional amplification step to incorporate adap-
ter regions (see Materials and Methods). Between 22.3
million and 25.6 million mapped sequence reads for
each of the five shRNA plasmid pools were obtained,
yielding a median number of reads per shRNA per 78 k
pool of between 107 and 162 (Table 2). Notably, 73,073
(93.4%) of expected shRNA sequences were detected in
the combined data from all five shRNA pools sequenced
(>121 million mapped reads) and 68,420 (87.5%) of
expected shRNA barcodes were detected in the human
78 k Even pool alone (Table 2). Comparison of the
sequence read frequency to GMAP intensity signal for
shRNA barcodes in the Even pool resulted in a positive
Spearman correlation of R = 0.37 (Figure 2a). By omit-
ting shRNA clones that were not enumerated in the
sequencing data by at least 16 reads and with a signal
intensity of at least log2 = 7.89 on the GMAP array, the
correlation improved to 0.42. While both the sequencing
and the chip hybridization methods provide an assess-
ment of shRNA relative concentration that is reproduci-
ble, the modest level of correlation between the signals
for these two types or readouts indicates that they have
significantly different relationships to absolute shRNA
concentration.
A major concern in using large shRNA pools with
microarray detection strategies is the extent to which
cross-hybridization occurs.T oa d d r e s st h i si s s u e ,w e
measured the frequency of significant signals from
GMAP shRNA features that did not correspond to
constituents of a pool of shRNA probes. Specifically, we
examined features corresponding to the 78 k mouse
pool for signal when the 78 k human pool was hybri-
dized. Features on GMAP that had 100% identity to
shRNAs in both the mouse and human pools were
removed from the analysis. After doing so, we found
that only 2637 of 77,690 (3.39%) mouse 78 k pool fea-
tures had significant signal (log2≥7.89). From this find-
ing, we infer that amongst the human shRNA features,
the cross-hybridization rate from human 78 k pooled
probe would be similar.
Frequency distribution plots of sequencing read
counts for the Even, 4x, 16x, 64x and 2-20x pools (Fig-
ure 2b,c) show similar characteristics to the distributions
generated for the same pools by microarray detection on
the GMAP (Figure 1b,c) with some exceptions. First, the
distributions tended to be slightly wider for sequence
data. Second, the distributions for sequence data exhibit
a linear relationship that more accurately reflects the
actual experimental dilution of shRNAs in the dilution
pools. In other words, the distribution curves for
sequencing data tend to center over the correct fold-
dilution. These observations demonstrate that sequen-
cing barcode pools results in linear, quantifiable signals
whereas microarray detection displays nonlinear signal,
a behaviour previously observed by Pierce et al. [27]. In
addition, the dynamic range of signal obtained from
GMAP is compressed relative to deep sequencing (Addi-
tional file 1, Figure S5). However, these differences
aside, overall, GMAP detection of shRNA sequences was
similar to sequencing-basedd e c o n v o l u t i o ni ni t ss e n s i -
tivity and quantitative reproducibility over a range of
shRNA concentrations.
Microarray experiments have historically suffered from
subtle to substantial differences in data produced from
the same or similar templates when performed on dif-
ferent dates, by different users, or in different locations
[28]. A candidate method to enable detection and/or
correction of these differences is to include a standard
set of synthetic oligonucleotide probes that are “spiked”
into array hybridization mixtures in defined amounts.
These hairpin spike-in (HPSI) probes, designed to have
identical length and similar sequence characteristics to
shRNAs, may be used as yardsticks for artifact detection
and data normalization methods. We replicated 25 clus-
ters of 200 HSPI features across the GMAP (Table 1).
Spatially localized signal intensity fluctuations between
HSPI clusters may indicate potentially poor hybridiza-
tion or washing performance, contamination, or physical
damage to the array surface. As a trial, 12 HSPI probes
were tested in replicate array hybridizations to examine
their hybridization characteristics and it was found that
they behaved in a dose-dependent manner similar to
labelled shRNA probes (Additional file 1, Figure S6).
Table 2 Summary of shRNA pool deconvolution by next-
generation sequencing
Statistic Even 4x 16x 64x 2-20x
Reads passed
filter
22407757 24596943 24793754 24304519 25684516
Mapped reads 22296083 24504006 24687271 24235485 25605983
Unmapped
reads
111674 94937 106483 69034 78533
Unmapped
reads %
0.5 0.39 0.43 0.28 0.31
1
st quartile 40 34 26 35 21
Median 153 149 140 162 107
Mean 315 352.4 351.6 350.7 370.2
3
rd quartile 375 408 404 417 385
Max 17960 19360 21750 20000 29460
Uncounted 9784 10748 10045 10983 10739
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Figure 2 Comparison of sequencing and GMAP performance with high complexity shRNA pools. (a) Scatter plot of GMAP array signal
intensity (X-axis) versus sequencing read number (Y-axis) for shRNA clones from the human Even shRNA pool. (b) Distribution plots of Illumina
sequencing data for a dilution series of shRNAs in separate pools. 4x, 16x, and 64x curves are plotted as the distribution of log2 difference
between the number of sequencing reads for shRNAs in the dilution series and their read count in the reference (Even) pool. The 1x curve is
plotted as the log2 difference between a group of undiluted shRNAs in the 4x pool and the same shRNAs in the Even pool. (c) Distribution plots
of Illumina sequencing data for a dilution series of shRNAs within the same pool. 2x, 5x, 10x, and 20x curves are plotted as the distribution of
log2 difference between the number of sequencing reads for groups of diluted shRNAs and their read count in the reference (Even) pool. The
1x curve is plotted as the log2 difference between a group of undiluted shRNAs in the 2x-20x pool and the same shRNAs in the Even pool. (d)
Distribution plots of GMAP features data for a dilution series of shRNAs contained within sub fractions of a ~90,000 shRNA pool where the
probe was amplified from shRNA plasmid template DNA. (e) Distribution plots of GMAP features data for a dilution series of shRNAs contained
within sub fractions of a ~90,000 shRNA pool where the probe was amplified from genomic DNA of A549 cells infected with lentiviral pools. 2x,
5x, 10x, and 20x curves are plotted as the distribution of log2 difference between the array signal for groups of diluted shRNAs in the 90 k
Dilution pool and their signal in the 90 k Reference pool. The 1x curve is plotted as the log2 difference between a group of undiluted shRNAs in
the 90 k Dilution pool and the same shRNAs in the 90 k Reference pool.
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screening experiment, two large pools of 90,408
shRNAs, each targeting ~18,000 human genes were con-
structed. For the “90 k Reference” pool, all of the
shRNA plasmids were combined at approximately equal
concentrations, while a dilution series pool, the “90 k
Dilution”, contained four sub-sets of ~3,500 shRNAs
each that were diluted 2-fold, 4-fold, 10-fold or 20-fold
with respect to their counterparts in the 90 k Reference
pool. Distribution plots of shRNA log2 signal difference
between the 90 k Dilution and the 90 k Reference pools
demonstrate that the diluted sub fractions are clearly
resolvable (Figure 2d). We generated lentivirus from the
90 k Reference and 90 k Dilution pools that was subse-
quently used to infect A549 cells. Genomic DNA pre-
pared from these cells containing integrated shRNA-
expressing cassettes was used as template for probe gen-
eration and GMAP hybridization. The resulting distribu-
tion plots of log2 signal difference between the 90 k
Dilution and 90 k Reference pools post-infection (Figure
2e) were very similar to those achieved with probe gen-
erated from plasmid template for the 90 k pools and 78
k pools. A scatter plot comparing data for the 90 k
Reference pool derived from plasmid and genomic DNA
template reveals excellent correlation (R > 0.97, see
Additional file 1, Figure S7) further demonstrating that
reliable results can be obtained from pooled cell-based
screening experiments with shRNA pools spanning
essentially the entire human genome with coverage of 4-
5 shRNAs per gene.
To enable pooled ORF over-expression screening
using the GMAP array to detect and quantify ORF
sequences, we designed features against 22,449 distinct
human ORF sequences in the Mammalian Genome Col-
lection (MGC) (Table 1 and [29,30]). Between 1 and 8
probes were designed against each ORF, with a median
of 7 probes per sequence. For comparative purposes, we
also included up to three additional features found on
the human expression profiling Affymetrix Gene 1.0 ST
array for 18,088 of these sequences. To assess the
GMAP performance with human ORF hybridization, we
developed 41 plasmid pools of entry clones (15,347
open reading frames) from the human ORFeome v5.1
collection that were combined to generate a single mas-
ter pool. Subsequently, 15,347 ORFs were amplified in
pooled format with common flanking primers, labelled
and hybridized to both the Human Gene 1.0 ST array
and GMAP arrays in duplicate (see Materials and
Methods). Signal for features shared between the two
arrays was highly correlated (Pearson’s correlation coef-
ficient R = 0.953, Figure 3a), with similar distribution of
signal across the features for each array (Figure 3b) and
similar signal-to-noise ratios (data not shown). These
results demonstrate that the GMAP has robust
reporting of ORF data, and suggests that the GMAP can
be used for a number of human gene assays including
human ORF/cDNA overexpression screens.
To compare the dynamic range of signal for huORF
and huGene features on the GMAP, five different quan-
tities of probe generated from ORFeome plasmid pools
were hybridized to GMAP in duplicate. The resulting
data indicated that two-fold changes in probe input pro-
duced highly correlated signals across a 16-fold dynamic
range (Figure 3c), thus we combined huORF and
huGene features into one feature set. Our methodology
to detect ORF sequences on microarrays depends on
common flanking primers that amplify entire open read-
ing frames. This provides an opportunity to examine the
u t i l i t yo ft h et h r e es e t so fO R Ff e a t u r e so nt h eG M A P
microarray, including the 22-mer hairpin features
designed to detect shRNA barcodes. The signal concor-
dance between sequence identity-conserved hORF fea-
tures and shRNA features on GMAP was
interchangeable across the entire spectrum of probe
concentrations (Figure 3d). This concordance can be
further exploited to expand the feature set for each gene
to obtain more accurate measurements of ORFs in a
given hybridization mix, which is particularly important
for discriminating isoforms in a polyclonal library of
open reading frames.
GMAP also contains triplicate copies of features for
the collection of ~16,000 20 nucleotide Yeast Knockout
Collection barcodes[2], and single copies of ~12,000 25
nucleotide yeast ORF-specific features (Table 1). The
yeast ORFs represented on this array are identical to
those found on the Tag4 barcode array with two distinct
probes designed against each of 5718 yeast ORF
sequences. These features can serve as additional con-
trols as they are non-homologous to the shRNA or
human ORFeome probes on the GMAP. The yeast fea-
tures on the GMAP display comparable performance to
the TAG4 microarray (Affymetrix) from which they are
derived (data not shown).
Am a j o rh u r d l et ou s i n gan e wm i c r o a r r a yp l a t f o r mi s
the informatics associated with data extraction and analy-
sis. The GMAP chip contains several subsets of features,
some of which can be organized as traditional Affymetrix
f e a t u r es e t sa sw e l la sf e a t u r e sf o ri n t e r r o g a t i o no fs h o r t
input DNA sequences (shRNA barcodes). Extraction of
signal from these arrays can be done with the Affymetrix
Power Tool (APT) collection. To help aid adoption of
the GMAP, we have developed a Java application to allow
data reorganization, graphical summaries and down-
stream analysis of the datasets extracted from these
arrays (files and applications available online at http://
chemogenomics.med.utoronto.ca/supplemental/gmap/).
This application makes use of a variety of R and Biocon-
ductor libraries (see Materials and Methods).T h eR
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Page 7 of 13functions that we have developed for this analysis will
also be available as scripts/libraries to allow end users to
work directly in the R environment. The current func-
tionality of the application includes methods to extract
signals into a single tab-delimited file for subsets of fea-
tures and GC-matched background signal, normalization
procedures, routines to generate signal ratios against one
or more reference chips with options to fine-tune ana-
lyses and standard or user-defined annotation files for
merging analyzed signal.
Conclusions
Our goal was to develop a comprehensive and standar-
dized microarray platform for quantification of pooled
screening results using commercially available gene
expression modulation libraries for human, mouse and
budding yeast cells. The advantages of a standardized
microarray are many-fold. First, a highly validated
microarray is invaluable to research labs that want to
adopt compatible screening approaches but do not have
extensive resources to build, test and optimize a custom
a) b)
d) c)
R
Figure 3 Quality of human ORF features on GMAP chip. (a) Intensity signals from the GMAP array (X-axis) plotted against signals from the
Human Gene 1.0 ST array (Y-axis) following amplification of human ORFeome v5.1 pools and hybridization of the resulting probe to each of
these arrays. Common features between the two arrays were used to calculate the Pearson correlation coefficient. (b) Distribution of signal
intensities from replicate GMAP or Human 1.0 ST arrays as described in (a) for shared features. Hybridization behaviour for the huORF features
compared to the (c) huGene features or the (d) 22-mer hairpin features for corresponding genes.
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Page 8 of 13barcode microarray themselves. The GMAP presents an
accessible solution because the obstacle of designing,
constructing, and testing of the array as well as develop-
ment of rigorous SOPs has already been overcome. Sec-
ond, screening costs are reduced since the GMAP
supports multiple commercially available functional
screening approaches in a single solution. As such, indi-
vidual labs or facilities do not have to re-optimize hybri-
dization conditions for different microarray platforms,
and a single framework can be used for data extraction
and quality control analysis. Third, a standard microar-
ray permits use of uniform methods across the many
laboratories using these gene modulation libraries.
Lastly, a multipurpose array can serve as a useful valida-
tion tool as new technologies for detecting barcodes uti-
lizing deep sequencing mature and become more widely
u s e d .T oe n a b l ef a c i l ea d o p t i o no ft h eG M A Pa r r a yf o r
large-scale screen deconvolution, we have also provided
a series of supplemental protocols and software tools to
help extract data from functional screens using commer-
cially available gene modulation libraries.
A thorough comparison of barcode detection strate-
gies for large, complex shRNA pools has been lacking in
the literature. We undertook such a comparison with
pools comprised of ~78,000 and ~90,000 distinct lenti-
viral shRNAs, the largest such shRNA screening pools
described to date. We directly compared microarray
detection with deconvolution by Illumina deep sequen-
cing and conclude that, at least in the current context,
data quality is comparable using either method. For
many or most users, the array-based read-out is cur-
rently more cost-effective on a per-sample basis when
costs per sample are tabulated. Equally important as
cost for many researchers is the turn-around time
required for sample preparation, sample run time and
data acquisition/processing, which is currently accom-
plished more rapidly using microarrays. Sample run
time on the GMAP chip spans ~18 hours between
probe application, hybridization, washing and scanning.
Typical microarray platform equipped labs or core facil-
ities should be able to easily accommodate more than
30 experimental samples in a typical work-week.
In addition to examining a plasmid pool containing
>78,000 shRNA clones, we also simulated a cell-based
dropout screen with a larger pool of >90,000 shRNA
clones. Genomic DNA was isolated from each of the
transduced populations and shRNA barcodes were
detected using the GMAP. Importantly, the resolution
of barcode detection was nearly equivalent whether the
starting template was from plasmid DNA or genomic
DNA. This experiment demonstrates that with the pro-
tocols developed here, the GMAP offers an effective and
efficient means of screening very large pools in a cellular
context. Our trials with complex shRNA and human
ORF pools demonstrate that the GMAP array is capable
of efficiently quantifying human and mouse genome-
scale gene modulation screens. As well, the GMAP chip
detection performance is equally suited for quantifying
shRNA abundance in lower complexity pools. The
GMAP array is not limited to use with the pooled
reagents described here - in fact, any screen which uses
the yeast deletion barcodes or TRC shRNA sequences as
molecular barcodes can be analyzed using the GMAP
array. Further generations of GMAP, utilizing even
higher feature-count microarrays, could be expanded to
include other shRNA and/or ORF libraries. However,
benefits of such an expansion would have to be weighed
against the increased cost of such expanded arrays. Gen-
erating specific arrays corresponding to different shRNA
libraries might be more efficient and cost effective. In
summary, this cost-effective platform provides any aca-
demic laboratory with access to a standardized array
and a suite of methods and analytical tools to perform
systematic genome-scale genetics on mammalian cells.
Materials and methods
Cell lines and growth conditions
BT-474 and A549 cells were obtained from ATCC and
maintained in DMEM (Wisent Inc.) + 10% FBS (Life
Technologies-Invitrogen) at 37°C and 5% CO2.
HSPI probe design
Spike-in sequence-feature combinations were selected so
that their perfect match Tm profiles (computed by
MELTING[31]) would be similar to shRNA-feature
combinations, but any mismatch Tm profiles would be
significantly lower than the lowest shRNA-feature Tm
profile. We computed Tm only for instances in which
spike-in sequences had at least 13 bases of sequence
identity to known shRNA features. Sequences could
share 13 bases of identity anywhere within the designed
21-mer. Candidate sequences with fewer than 13 bases
of identical sequence to any shRNA feature sequence
were retained without Tm evaluation as unlikely to
cross-hybridize, and candidate sequences with more
than 19 bases of sequence similarity were eliminated
outright without evaluating Tm. The top 200 sequences
were selected for inclusion as spike-in features on the
GMAP array.
Pooled libraries
All shRNA pools and constructs in this study were
derived from the RNAi Consortium lentiviral libraries
[11,14,22] available from Sigma-Aldrich and Thermo-
Fisher-Open Biosystems. The human and mouse 78 k
shRNA lentivirus plasmid pools were assembled by
combining equal proportions of ten sub-pools of ~8,000
clones each targeting either ~78,000 human or ~78,000
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Page 9 of 13mouse transcripts. Dilution pools were constructed by
the same method, except that diluted sub-pool fractions
were reduced in their representation in the 78 k pool by
the indicated amounts. Lentivirus pools were generated
from pooled lentiviral plasmid DNA. 90 k plasmid pools
were constructed by combining ~3500-4000 member
shRNA sub-pools together. These sub-pools consisted of
concentration-normalized plasmid. Dilutions were pre-
pared as described for 78 k pools. The human ORF pool
was derived from the human ORFeome v5.1 clones
[23,24] available through ThermoFisher-Open Biosys-
tems. 41 subpools of plasmid DNA were generated from
15,347 entry clones where each subpool contained ~380
human ORFs. A master hORF pool was derived from
equivalent amounts of each of the 41 subpools normal-
ized for the number of hORFs in each subpool.
Pooled lentiviral infections
7×1 0
7 A549 cells per replicate were infected with
either 90 k Reference or 90 k Dilution lentiviral shRNA
pools at an MOI of 0.3-0.4. After four days of selection
in puromycin-containing medium to eliminate unin-
fected cells, genomic DNA was prepared from shRNA-
containing cell populations (Blood Maxi prep kit, Qia-
gen). 7 × 10
7 BT474 cells were infected with the human
shRNA pool at an MOI of 0.3-04. After two days of
selection in puromycin-containing medium to eliminate
uninfected cells, genomic DNA was prepared from
shRNA-containing cell populations.
shRNA probe preparation (half-hairpin barcodes)
To create microarray probe from shRNA pools, a master
mixture for each sample containing template DNA (78 k
shRNA plasmid pools = 250 pg, 90 k plasmid shRNA
pools = 288 pg, genomic DNA = 30 μg), 2x PCR buffer,
2x enhancer solution, 300 μM each dNTP, 900 nM each
oligonucleotide primer (PCR_B-fw 5’-Biotin-AATG-
GACTATCATATGCTTACCGTAACTTGAA-3’ and
PCR_rev 5’-TGTGGATGAATACTGCCATTTGTCTC-
GAGGTC-3’), 1 mM MgSO4, 45 units of Platinum Pfx
polymerase (Invitrogen), and water to 1200 μl was cre-
ated and divided into 100 μl aliquots. The amplification
reaction was performed by denaturing once at 94°C for
5 minutes, followed by (94°C for 15 seconds, 55°C for
15 seconds, 68°C for 20 seconds)x30, 68°C for 5 min-
utes, then cooling to 4°C.
When electrophoresed on a 2% agarose gel, it is
expected that there should be a preponderance of an
apparent 178bp PCR product, and as little as possible of
an apparent 225bp product. Both bands on the gel repre-
sent amplified shRNA barcode sequences, but the upper,
slower migrating band is composed of two DNA strands
in a cruciform structure, centered around the palindro-
mic shRNA sequence, which is not suitable for further
processing into a GMAP probe. DNA in this structure is
resistant to restriction enzyme activity at the XhoI
restriction site between the shRNA palindrome
sequences. Application of PCR product containing a mix-
ture of two apparently different products to a denaturing
urea gel resolves a single size species of DNA (data not
shown). If PCR reactions are favouring cruciform pro-
duct, reducing the number of cycles in the PCR reaction
will favour the linear product (data not shown). PCR pro-
ducts are immediately purified using the QIAquick PCR
purification kit (Qiagen) since long-term storage at 4°C
or -20°C enables the conversion of linear product to cru-
ciform DNA. The purified 178bp PCR product is then
digested with XhoI (New England Biolabs) for 2 hours at
37°C to generate a thermo-stable half-hairpin probe. The
digested samples are separated on 2% agarose gels with
lanes large enough to accommodate 150 μl of sample.
Using sterile materials, the half-hairpin probes (~106bp)
are excised from the gel and purified using a gel extrac-
tion kit (QIAGEN). To remove remaining salts, the probe
DNA may be passed through a PCR cleanup column, and
eluted in a final volume of 30 μl.
GMAP shRNA probe hybridization
Microarrays were pre-hybridized by one wash with 40°C
10 mM NaOH, followed by incubation at 40°C for 10
minutes with rotation at 40 rpm with a second volume
of 10 mM NaOH. The arrays were then slowly washed
with 3-5 ml 6x SSPE, 0.0001% Tween 20, followed by
filling and incubation for 10 minutes at 40°C with rota-
tion at 40 rpm with 0.0005% Triton X-100. Arrays were
then emptied, rinsed twice, then filled with 6x SSPE,
0.0001% Tween 20, and incubated for 2 hours at 40°C
with rotation at 40 rpm.
Hybridization solutions consisted of 2 μg of probe for
78 k shRNA pools (2.3 μg for 90 k shRNA pools) in buf-
fer containing 1x MES, 0.89M NaCl, 20 mM EDTA,
0.0001% Tween 20, 0.5 mg/ml BSA, 0.1 mg/ml herring
sperm DNA, 0.05 nM biotinylated B2 oligo (Affymetrix),
10% DMSO, 20 μM each blocking oligos (Block_1 5’-
AATGGACTATCATATGCTTACCGTAACTTGAA-3’,
Block_2 5’-TTCAAGTTACGGTAAGCATATGATAG-
TCCATT-3’,B l o c k _ 35 ’-GTATTTCGATTTCTTGG-
CTTTATATATCTTGTGGAAAGGACGAAACACCG-
3’,B l o c k _ 45 ’-CGGTGTTTCGTCCTTTCCACAAGA-
TATATAAAGCCAAGAAATCGAAATAC-3’), and ster-
ile water to a final volume of 138 μl. Samples in buffer
were denatured at 95°C for 10 minutes, incubated at 40°
C for 5 minutes, collected by centrifugation then applied
to arrays, which were incubated for 16 hours at 40°C at
60 rpm. Arrays were stained with SAPE labeling mix (1x
MES staining buffer, 2 mg/ml BSA, 10 μg/ml streptavi-
din-phycoerythrin), and washed on an Affymetrix flui-
dics station, then scanned. More complete shRNA probe
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Page 10 of 13preparation and hybridization protocols are included in
Additional file 2.
Illumina sequencing
PCR product was prepared as described above for
GMAP shRNA probe preparation except that 27 cycles
of PCR were employed when amplifying from pooled
plasmid DNA. Purified PCR product DNA was used as
a template for a second round of amplification in order
to incorporate Illumina adapter sequences. Each 100 μl
reaction contained 5 ng of template, 2x PCR buffer, 2x
enhancer solution, 300 μM each dNTP, 900nM each for
Adapter A (5’-AATGATACGGCGACCACCGAAATG-
GACTATCATATGCTTACCGTAACTTGAA-3’)a n d
Adapter B (5’-CAAGCAGAAGACGGCATACGATGT-
GGATGAATACTGCCATTTGTCTCGAGGTC-3’),
1m MM g S O 4, 3.75 units of Platinum Pfx polymerase,
and water to 100 μl. The PCR reaction was performed
by denaturing at 94°C for 5 minutes, followed by (94°C
for 15 seconds, 55°C for 15 seconds, 68°C for 20 sec-
onds)x16, 68°C for 5 minutes, then cooling to 4°C. The
resulting 218bp product was purified by electrophoresis
in 2% agarose followed by gel extraction. Libraries were
initially quantified by the Quant-IT fluorescent assay
(Invitrogen), and fragment size was confirmed using a
Bioanalyzer high sensitivity chip in a 2100 Bioanalyzer
(Agilent Technologies). Libraries were diluted to ~15nM
concentration, and concentration was confirmed using
commercially available qPCR standard on 1:1000 dilu-
tions of library samples. DNA templates were then
diluted to 8pM as per the Illumina cBot user guide, and
clusters were generated on a single read flowcell using
the Illumina cBot. Each dilution pool was run in a sepa-
rate lane. Using an Illumina GAIIx instrument, sequence
was collected for 22 bases using the primer SeqshRNA
(5’-GATTTCTTGGCTTTATATATCTTGTGGAAAG-
GACGAAACACCG-3’).
Illumina data processing
Raw reads were generated using Illumina’s Offline Base
Caller software (v1.61). Reads that passed quality filter-
ing were extracted from the QSEQ files and merged
into FASTQ files using a custom BASH script. Reads
were aligned to a synthetic chromosome, constructed by
interspersing the hairpin sense strand sequence with
79nt of random sequence, using MAQ v0.7.1 [32] with
default parameters. The synthetic chromosome and hair-
pin index are available upon request. Aligned sequences
were matched to individual hairpin IDs if the alignment
start site corresponded with the correct starting nucleo-
tide of the hairpin sequence (i.e.: sequences with mis-
matches on the first nucleotide were removed) and the
MAQ quality score was ≥50. This quality threshold
allowed one mismatch over the 21nt sequence. If a read
mapped to one of the 227 shRNA barcode sequences
duplicated in the shRNA library, it was counted once
for each of the duplicate hairpin IDs. Reads were deter-
mined in a single replicate experiment, and counts were
log2 transformed prior to further analysis.
human ORF probe preparation and hybridization
Human ORFs were amplified from the master hORF
pool where each hORF was contained within the
pDONR223 plasmid. Five reactions were carried out in
a5 0μL volume containing 25 μLo f2 xP h u s i o nF l a s h
High-Fidelity Master Mix (Finnzymes), 400nM of each
primer and 10 ng of plasmid. The reaction times and
temperature were 1 minute at 98°C for 1 cycle; 10 sec-
onds at 98°C, 20 seconds at 60°C, and 4 minutes at 72°C
for 30 cycles; 10 minutes at 72°C for 1 cycle. The
sequences of the forward and reverse primers specific
for the cloned human ORFs were 5’-CACGACGTTG-
TAAAACGACGGCCAGTC-3’ and 5’-GAGCTGCCAG-
GAAACAGCTATGACCATG-3’ respectively. PCR
products were purified (Qiagen) and pooled. Purified
PCR product was biotinylated (8 reactions, 500ng per
reaction) using a BioPrime DNA labelling kit (Invitro-
gen) and unincorporated biotin-14-dCTP was removed
by passing the samples through Sephadex G-50 columns
(GE Healthcare). Microarrays were pre-hybridized by
adding 130 μL of Hybridization buffer and incubating
for 10 minutes at 45°C and 60 rpm. The hybridization
mix contained 2x hybridization buffer, 5nM B2 oligo,
50x Denhardt’s solution and biotinylated PCR product.
Different amounts of labelled probe were added to Affy-
metrix arrays and hybridized at 45°C for 17 hours with
a rotation of 60 rpm. GMAP-UTS520601 Affymetrix
arrays were hybridized with 7 μg, 3.5 μg, 1.75 μg, 0.875
μg or 0.4375 μg of biotinylated PCR product obtained
from the human ORFeome 5.1 collection. The Human
Gene 1.0 ST arrays were hybridized with 3.5 μgo fs a m -
ple. Probe was hybridized to the arrays for 17 hours at
45C and 60 rpm. Arrays were stained with SAPE label-
ling mix (2x MES staining buffer, 20 mg/mL BSA, and 1
mg/mL streptavidin-phycoerythrin), washed on an Affy-
metrix fluidics station and scanned.
GMAP data extraction and processing
Feature signal was extracted from the GMAP and
TRCBC arrays using Affymetrix Power Tools v.1.12.0
(APT, http://www.affymetrix.com). The GMAP chip
contains triplicate features per shRNA, which we sum-
marized by using the median value. GC-background
(GCbg) correction for non-specific probe binding was
performed with APT, using feature signals derived from
33,894 GC-background probes on the array. Normaliza-
tion of replicate arrays was performed with the Biocon-
ductor affy package (v1.26.1) in R, using Cyclic Loess
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Page 11 of 13based on the ‘MA-plot’ of pairs of arrays. Distribution
plots generated from the raw, GCbg-corrected, and
Loess-normalized signal intensities demonstrated that
GCbg-correction served to increase the differentiation
between signal from the features corresponding to
shRNA pool probes and those features on the GMAP
without corresponding partners in the probe pool. while
normalization reduced the variance between replicates
(Additional file 1, Figure S8).
Web-based tool for GMAP
We have developed a Java front-end through which this
extraction and analysis can be accomplished by users
outside our laboratories. The current functionality of
the application includes the following:
1. Extraction of signal from a set of Affymetrix. CEL
files into a single tab-delimited file. The extracted
signal can be limited to a specific subset of features
and GC-matched background signal can be
subtracted.
2. Signal across chips can be normalized using a
variety of procedures. Graphical output is generated
for assessment of normalization.
3. Currently, the primary use of this chip is for
assessment of strain abundance during pooled
growth in a variety of systems that correspond to
features on this array. This includes strains with
integrated molecular barcodes, transduced with
shRNA sequences, or hORF sequences. The Java
application includes tools to calculate signal ratios
against one or more reference chips with a variety of
options available to fine-tune the analysis.
4. Extracted feature signal datasets can be further
reduced by limiting to features relevant to specific
pools. Standard or user-defined annotation files can
be merged with the analyzed signal.
This application, R scripts, links to supporting soft-
ware and examples of use are available on our supple-
mentary website http://chemogenomics.med.utoronto.
ca/supplemental/gmap/.
Additional material
Additional file 1: contains additional figures S1-S8 and the
corresponding figure legends.
Additional file 2: contains details methods for GMAP probe
generation and hybridization as well as recipes and reagents.
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